Cabio Biotech Wuhan Co., Ltd. (688089)
Market Closed
11 Aug, 06:57
SSE SSE Primary ¥
7. 85
-0.02
-0.2541%
¥
3.95B Market Cap
- P/E Ratio
0.8% Div Yield
2.1M Volume
- Eps
¥ 7.87
Previous Close Want to track 688089 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cabio Biotech Wuhan Co., Ltd. (688089) Statistics
Valuation metrics
Market Cap 3.95B
Enterprise value 1.28B
Trailing P/E (ttm) 18.85
Forward P/E -
PEG ratio -0.36
Price/Sales (ttm) 3.03
Price/Book (mrq) 0.82
Enterprise Value/Revenue 2.98
Enterprise Value/EBITDA 10.37
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 7.12M
Average volume (90 days) 3.39M
Price summary
52-Week low 6.91
52-Week high 31.13
Beta -
50-Day moving average 9.9
200-Day moving average 15.21
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.2
Trailing annual dividend yield 0.026%
5-Year annual dividend yield -
Payout ratio 0.04
Dividend Date 10 Jul 2025
Ex-Dividend Date 10 Jul 2025
Last split factor 1:1
Last split Date 18 Jul 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.16%
Operating margin 0.17%
Operational effectiveness
Return on assets 0.04%
Return on equity 0.04%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 2.57
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.41
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.31
Total debt (mrq) -
Total Debt/Equity (mrq) 0.13
Current ratio (mrq) 3.76%
Book value per share (mrq) 9.53
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
